Theratechnologies Stock Analysis

THTX Stock  USD 1.46  0.05  3.55%   
Theratechnologies is undervalued with Real Value of 5.47 and Target Price of 17.75. The main objective of Theratechnologies stock analysis is to determine its intrinsic value, which is an estimate of what Theratechnologies is worth, separate from its market price. There are two main types of Theratechnologies' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Theratechnologies' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Theratechnologies' stock to identify patterns and trends that may indicate its future price movements.
The Theratechnologies stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Theratechnologies is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Theratechnologies Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Theratechnologies' ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

Theratechnologies Stock Analysis Notes

About 51.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.91. Theratechnologies had not issued any dividends in recent years. The entity had 1:4 split on the 31st of July 2023. Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company was incorporated in 1993 and is headquartered in Montreal, Canada. Theratechnologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. To find out more about Theratechnologies contact Paul Lvesque at 514 336 7800 or learn more at https://www.theratech.com.

Theratechnologies Quarterly Total Revenue

23.45 Million

Theratechnologies Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Theratechnologies' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Theratechnologies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Theratechnologies generated a negative expected return over the last 90 days
Theratechnologies has high historical volatility and very poor performance
Theratechnologies may become a speculative penny stock
Theratechnologies has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 81.76 M. Net Loss for the year was (23.96 M) with profit before overhead, payroll, taxes, and interest of 56.22 M.
Theratechnologies currently holds about 36.46 M in cash with (5.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38.
Latest headline from globenewswire.com: Theratechnologies nomme JordanZwick son conseil dadministration

Theratechnologies Upcoming and Recent Events

Earnings reports are used by Theratechnologies to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Theratechnologies previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024
Upcoming Quarterly Report
View
10th of April 2024
Next Financial Report
View
30th of November 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
31st of August 2023
Last Quarter Report
View
30th of November 2022
Last Financial Announcement
View

Theratechnologies Largest EPS Surprises

Earnings surprises can significantly impact Theratechnologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-02-28
2022-11-30-0.08-0.09-0.0112 
2019-10-08
2019-08-31-0.01-0.02-0.01100 
2018-02-07
2017-11-30-0.02-0.03-0.0150 
View All Earnings Estimates

Theratechnologies Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Theratechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Theratechnologies backward and forwards among themselves. Theratechnologies' institutional investor refers to the entity that pools money to purchase Theratechnologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Hamilton Capital Management Inc2023-12-31
44.1 K
Beacon Pointe Advisors, Llc2023-12-31
26 K
Geode Capital Management, Llc2023-12-31
25.7 K
Creative Financial Designs Inc2023-12-31
25 K
Bare Financial Services Inc2023-12-31
23.9 K
Pnc Financial Services Group Inc2023-12-31
21.7 K
Ubs Group Ag2023-12-31
18.5 K
Kohmann Bosshard Financial Services, Llc2023-12-31
15.4 K
Greatmark Investment Partners Inc2023-12-31
14.9 K
Nantahala Capital Management, Llc2023-12-31
5.4 M
Soleus Capital Management, L.p.2023-12-31
4.8 M
Note, although Theratechnologies' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Theratechnologies Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 65.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theratechnologies's market, we take the total number of its shares issued and multiply it by Theratechnologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Theratechnologies Profitablity

Theratechnologies' profitability indicators refer to fundamental financial ratios that showcase Theratechnologies' ability to generate income relative to its revenue or operating costs. If, let's say, Theratechnologies is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Theratechnologies' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Theratechnologies' profitability requires more research than a typical breakdown of Theratechnologies' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.29) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17.
Last ReportedProjected for 2024
Return On Capital Employed(0.31)(0.30)
Return On Assets(0.35)(0.37)
Return On Equity 1.32  1.14 

Management Efficiency

Theratechnologies has return on total asset (ROA) of (0.0633) % which means that it has lost $0.0633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.1686) %, meaning that it created substantial loss on money invested by shareholders. Theratechnologies' management efficiency ratios could be used to measure how well Theratechnologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to -0.3 in 2024. Return On Assets is likely to drop to -0.37 in 2024. At this time, Theratechnologies' Non Current Assets Total are fairly stable compared to the past year. Other Assets is likely to rise to about 2.2 M in 2024, whereas Total Assets are likely to drop slightly above 65.2 M in 2024.
Last ReportedProjected for 2024
Price Book Value Ratio(1.79)(1.70)
Enterprise Value Multiple(10.14)(9.63)
Price Fair Value(1.79)(1.70)
The analysis of Theratechnologies' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Theratechnologies' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Theratechnologies Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.725

Technical Drivers

As of the 28th of March, Theratechnologies has the Coefficient Of Variation of 13082.08, semi deviation of 5.21, and Risk Adjusted Performance of 0.0132. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Theratechnologies, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Theratechnologies, which can be compared to its competition. Please validate Theratechnologies semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Theratechnologies is priced more or less accurately, providing market reflects its prevalent price of 1.46 per share. Please also confirm Theratechnologies total risk alpha, which is currently at (1.20) to double-check the company can sustain itself at a future point.

Theratechnologies Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Theratechnologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Theratechnologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Theratechnologies Predictive Daily Indicators

Theratechnologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Theratechnologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Theratechnologies Forecast Models

Theratechnologies' time-series forecasting models are one of many Theratechnologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Theratechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Theratechnologies Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Theratechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Theratechnologies shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Theratechnologies. By using and applying Theratechnologies Stock analysis, traders can create a robust methodology for identifying Theratechnologies entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin(0.26)(0.27)
Operating Profit Margin(0.13)(0.12)
Net Loss(0.26)(0.28)
Gross Profit Margin 0.68  0.34 

Current Theratechnologies Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Theratechnologies analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Theratechnologies analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
17.75Strong Buy4Odds
Theratechnologies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Theratechnologies analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Theratechnologies stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Theratechnologies, talking to its executives and customers, or listening to Theratechnologies conference calls.
Theratechnologies Analyst Advice Details

Theratechnologies Stock Analysis Indicators

Theratechnologies stock analysis indicators help investors evaluate how Theratechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Theratechnologies shares will generate the highest return on investment. By understating and applying Theratechnologies stock analysis, traders can identify Theratechnologies position entry and exit signals to maximize returns.
Begin Period Cash Flow23.9 M
Long Term Debt50.7 M
Common Stock Shares Outstanding26.3 M
Total Stockholder Equity-20.9 M
Tax Provision421 K
Property Plant And Equipment NetM
Cash And Short Term Investments40.4 M
Cash34.1 M
Accounts PayableM
Net Debt24.9 M
50 Day M A1.5368
Total Current Liabilities47.3 M
Other Operating Expenses92.4 M
Non Current Assets Total14.5 M
Forward Price Earnings55.8659
Stock Based Compensation2.2 M
When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Theratechnologies Stock analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Managers
Screen money managers from public funds and ETFs managed around the world
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Is Theratechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Theratechnologies. If investors know Theratechnologies will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Theratechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.91)
Revenue Per Share
3.105
Quarterly Revenue Growth
0.095
Return On Assets
(0.06)
Return On Equity
(11.17)
The market value of Theratechnologies is measured differently than its book value, which is the value of Theratechnologies that is recorded on the company's balance sheet. Investors also form their own opinion of Theratechnologies' value that differs from its market value or its book value, called intrinsic value, which is Theratechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Theratechnologies' market value can be influenced by many factors that don't directly affect Theratechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.